Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

Research service necessary to execute a NAMRU SOUTH Zika study in Panama.

Active
ERP_PR_1301393620Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Naval Medical Research Unit South is seeking research services to support its Virology Department’s febrile and respiratory surveillance study, specifically in support of a Zika virus study in Panama. The government has conducted market research and determined that only Fundacion Ciudad del Saber possesses the unique capability to fully meet the technical and operational requirements of the study, making the procurement eligible for a sole source award under FAR 13.106-1(b)(i). No competitive solicitation exists, and this notice serves solely as an opportunity for other potential vendors to demonstrate their capability to perform the work. Interested parties must submit a capability statement not exceeding five pages in 10-point font or larger, containing detailed management, technical, and cost information with convincing evidence of their ability to fulfill the requirement. Submissions must be sent via email as a Word or PDF attachment to genaro.m.vasquez.ln@health.mil with the subject line “ERP PR_1301393620” no later than 12:00 PM local time on August 11, 2026. Responses consisting only of questions or requests for clarification will not be accepted. The government retains full discretion to proceed with a sole source award or open a competitive process based on the submissions received. The contracting office is located in Washington, DC, and the primary point of contact is Genaro Vasquez.

General Info

Sole source contract for Zika virus surveillance in Panama awarded to Fundacion Ciudad del Saber, with open submission period until August 11, 2026.

Agency

Department Of Defense → Naval Medical Research Unit SouthView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

DC, PER

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Naval Medical Research Unit South
Contacts1 person available
OfficeWASHINGTON, DC, 20521-3230, USA
Organization / Agency
Department Of Defense → Naval Medical Research Unit South
View Agency Profile
Office AddressWASHINGTON, DC, 20521-3230, USA
Contacts
Genaro Vasquez
contact@example.gov

Full Description

Show more

Naval Medical Research Unit South in Lima, Peru has a requirement to procure research service in support the Virology Department research studies of the febrile and respiratory surveillance study for the Virology Department.


If capable sources are not identified through this notice, then NAMRU South intends to award a sole source contract under the authority of FAR 13.106-1(b)(i) to Fundacion Ciudad del Saber.


Thru Market Research the Government identified that while these services can be procured independently on the Open Market, only Fundacion Ciudad del Saber is the only vendor that can support the requirement in its entirety as mandated by the study.


This Sole Source Intent is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Capability statements shall not exceed 5 (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source contract.


Capability statements are due by 12:00 PM Local Time, 11 August, 2026. Capability statements shall be submitted by e-mail ONLY as a Microsoft Word or Adobe PDF attachment to the following address: genaro.m.vasquez.ln@health.mil. Please use subject line "ERP PR_1301393620".


Contracting Office Address:


3230 Lima Pl, Washington DC, 20521


United States



Primary Point of Contact:


Martin Vasquez


genaro.m.vasquez.Ln@health.mil

Similar Contracts

Same NAICS industry code

NAICS: 541714
New
Federal
Neural Organoid Generation from iPSCsThe contract seeks the differentiation of 26 induced pluripotent stem cell lines into three-dimensional neural organoids using standardized, reproducible protocols optimized for research applications. The work requires precise control over differentiation conditions to ensure consistency and biological relevance across all lines, with an emphasis on defined, serum-free methodologies that minimize variability and enhance reproducibility. The resulting organoids will serve as model systems for neurological research and must be generated in compliance with established laboratory standards to support downstream analyses such as gene expression profiling, drug screening, or disease modeling. The effort is classified as a subcontract under NAICS code 541714 and is sponsored by the National Institutes of Health through the Department of Health and Human Services. Proposals must be submitted by the deadline of July 31, 2026, and the performance location is not specified, implying flexibility in where the work will be conducted as long as protocols and deliverables meet requirements.
National Institutes Of Health Olao

POSTED

1 day ago

DEADLINE

in 3 days
View Details
NAICS: 541714
New
Federal
Combines Synopsis Solicitation- iPSC DifferentiatiThe National Institutes of Health, through its Office of the Director and Office of Acquisitions, is seeking to award a firm fixed-price contract on a non-competitive basis to Oxford StemTech Ltd of Oxford, UK, for scientific support services related to the quality control of induced pluripotent stem cells and the generation and characterization of organoids using a subset of these cell lines. This acquisition is conducted under streamlined commercial item procedures outlined in FAR Subpart 12.6 and is not expected to exceed the simplified acquisition threshold, with authority derived from FAR 12.603, 41 U.S.C. 1901, and FAR 6.302-3(a)(2)(ii). The solicitation, identified by number 75N98026Q00878, serves as both the notice of intent and the sole solicitation document, eliminating the need for a separate formal request. The contract is classified under NAICS code 541714 and is being procured without competition due to the unique technical capabilities required and the specialized nature of the services. The response deadline for proposals is July 31, 2026, at 6:00 p.m. Eastern Time, with the posting date listed as July 27, 2026. All submissions must be directed to the designated point of contact, John R. Johnson, reachable via email at johnsonjr@mail.nih.gov, with the contract performance to be carried out in Bethesda, Maryland. The contract will be executed under the authority of the Department of Health and Human Services, and no set-asides or small business preferences are applicable. The offering entity, Oxford StemTech Ltd, has been identified as the only qualified source capable of delivering the required services, justifying the non-competitive approach under the specified regulatory exceptions.
National Institutes Of Health Olao

POSTED

1 day ago

DEADLINE

in 3 days
View Details
NAICS: 541714
New
Federal
Humanized Antibody Library Screening and Transferrin Receptor DevelopmentThe contract involves the customized screening of a humanized antibody library to develop a functional transferrin receptor, encompassing molecular design, in vitro selection, and optimization of binding affinity and specificity. The work requires advanced techniques in antibody engineering to identify and refine candidates capable of high-affinity, selective interaction with the transferrin receptor, with the goal of producing a therapeutically viable candidate. The scope includes iterative cycles of library screening, functional characterization, and structural optimization to enhance target binding while minimizing off-target interactions, ensuring the final product meets stringent performance benchmarks. This subcontract is issued under the NAICS code 541714 for research and development in the biological sciences and is associated with the National Institutes of Health through the Department of Health and Human Services. The place of performance is in Bethesda, Maryland, with a deadline for proposals set for July 31, 2026. The contract is expected to support biomedical innovation targeting receptor-mediated delivery systems and requires expertise in molecular biology, high-throughput screening, and protein engineering. No specific set-aside provisions are indicated, and the work is open to qualified subcontractors capable of delivering scalable, data-driven antibody development solutions within the defined timeline.
National Institutes Of Health Olao

POSTED

4 days ago

DEADLINE

in 3 days
View Details
NAICS: 541714
New
Federal
Recombinant Antibody Discovery & Engineering ServicesThe contract involves the discovery, humanization, and engineering of single domain antibodies designed to penetrate the blood-brain barrier using phage and yeast display platforms. This effort includes advanced antibody optimization through affinity maturation to enhance binding strength and specificity, as well as comprehensive stability testing to ensure functional integrity under physiological conditions. The work is scientifically focused on developing recombinant antibody formats capable of crossing the blood-brain barrier, a critical step for therapeutic applications targeting neurological diseases. This subcontract, issued by the National Institutes of Health under the Department of Health and Human Services, is classified under NAICS code 541714 for research and development in the physical, engineering, and life sciences. The opportunity was posted on July 24, 2026, with a response deadline of August 3, 2026. Performance is expected to take place in Bethesda, Maryland, 20892. The project does not specify a set-aside type or point of contact details, and the full solicitation can be accessed via the provided SAM.gov link for additional procedural or submission guidelines.
National Institutes Of Health Olao

POSTED

4 days ago

DEADLINE

in 6 days
View Details
NAICS: 541714
New
Federal
Bioinformatics and Data Analysis for Biomarker ResearchThe contract titled Bioinformatics and Data Analysis for Biomarker Research seeks to deliver computational analysis of high-throughput sequencing data with the goal of identifying and validating biomarker signatures, accompanied by the generation of detailed research reports. This effort is classified as a subcontract under NAICS code 541714 and is managed by the Department of Veterans Affairs through its 245-NETWORK Contract Office 5. The work is to be performed at a location in Washington, D.C., with a zip code of 20422. The opportunity was posted on July 24, 2026, and responses are due by August 7, 2026, at 5:00 PM EST. Although no specific set-aside designation is indicated, the contract is structured to support advanced bioinformatics capabilities essential for translational research in biomarker discovery.
245-NETWORK Contract Office 5 (36C245)

POSTED

4 days ago

DEADLINE

in 10 days
View Details
NAICS: 541714
New
Federal
Develop and Validate Transferrin ReceptorThe National Institutes of Health, under the Department of Health and Human Services, has issued a presolicitation notice for the development and validation of a transferrin receptor, identified by solicitation number 75N98026Q00866. This opportunity is open for responses until July 31, 2026, and was posted on July 24, 2026, with no set-aside provisions applied, making it open to all eligible entities. The work will be performed in Bethesda, Maryland, and falls under the NAICS code 541714, which corresponds to research and development in the physical, engineering, and life sciences. The primary point of contact for inquiries is Towanda Daniels, reachable via email at danielt@mail.nih.gov. Interested parties are directed to the official SAM.gov workspace link for further details and submission guidelines. The contract aims to support advanced scientific research focused on the transferrin receptor, likely to advance biomedical applications or therapeutic technologies. All proposals must adhere to the requirements outlined in the notice of intent, and submissions should be prepared with consideration for the technical scope, timeline, and performance standards expected by the NIH Office of Laboratory Animal Welfare. The contract is structured to enable innovation in molecular biology or drug delivery systems involving receptor targeting, with performance expected within the confines of federal research protocols and compliance standards.
National Institutes Of Health Olao

POSTED

4 days ago

DEADLINE

in 3 days
View Details
NAICS: 541714
New
Federal
Humanized single domain antibodies for therapeutic brain delivery​The National Institutes of Health Office of Extramural Research, under the Department of Health and Human Services, has issued a presolicitation for the development of humanized single domain antibodies designed for therapeutic delivery across the blood-brain barrier. The project, identified by solicitation number 75N98026Q00867, aims to advance novel antibody technologies capable of targeting brain-specific pathologies with enhanced precision and efficacy. All responses are due by August 3, 2026, and no set-aside provisions are applicable, meaning the opportunity is open to all eligible entities. The performance location is designated as Bethesda, Maryland, with the contract administration handled by the agency’s office at 20892. Primary point of contact for inquiries is Towanda Daniels, reachable via email at danielt@mail.nih.gov. The solicitation was posted on July 24, 2026, and all potential offerors are directed to the designated SAM.gov workspace for additional details and documentation. No NAICS code has been assigned at this stage, and the initiative reflects a strategic effort to enable breakthrough treatments for neurological disorders through innovative biotherapeutic platforms. Applicants must ensure full compliance with the requirements outlined in the attached Notice of Intent.
National Institutes Of Health Olao

POSTED

4 days ago

DEADLINE

in 6 days
View Details
NAICS: 541714
New
Federal
Notice of Intent to Award a Sole Source Contract – Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreakThe Food and Drug Administration is planning to award a sole source firm-fixed price purchase order to The University of Liverpool under simplified acquisition procedures for the sequencing of Bundibugyo virus disease during the 2026 outbreak, relying on FAR Part 6.103-1 which permits non-competitive procurement when only one responsible source exists. This action falls under the NAICS code 541714 for Research and Development in Biotechnology and is not open for competitive bidding, as the FDA has determined that The University of Liverpool is the only entity with the necessary expertise and capacity to meet the technical requirements for this highly specific viral sequencing effort. The contract is intended to support bioanalytical method development and sample analysis by providing critical reagents and reference standards for quantifying CYP enzyme substrates and metabolites in hepatocyte experiments during the outbreak response. Responses to this notice must be submitted by Ryan Alexander at ryan.alexander@fda.hhs.gov no later than 5:00 pm on July 29, 2026, and must include a detailed capability statement for any other organization seeking consideration, though the government retains full discretion to determine whether a response justifies competitive solicitation. The procurement is not a request for competitive quotes, and no set-aside is being applied. The contract will be administered from the FDA’s office in Rockville, Maryland, with performance primarily occurring in Liverpool, England, and the solicitation number is OC-2026-135667, issued on July 24, 2026.
Food And Drug Administration

POSTED

4 days ago

DEADLINE

in 1 day
View Details
NAICS: 541714
New
Federal
Procurement of lateral flow (LFA) strips for the rapid HIV nucleic acid diagnostic testThe Centers for Disease Control and Prevention is soliciting bids for the procurement of 4,000 lateral flow strips intended for use in a rapid HIV nucleic acid diagnostic test under a firm-fixed-price contract, issued as a Request for Quote in accordance with FAR Subpart 12 for commercial items. The solicitation number is 75D30126Q79099, with a performance period of August 1, 2026, to December 31, 2026, and an option to extend services for up to six additional months. Proposals must be submitted electronically to Eugene Gutierrez at zvm0@cdc.gov no later than 3:00 P.M. Eastern Standard Time on Friday, July 24, 2026, with no telephonic or paper submissions accepted. The place of performance is the CDC facility at 1600 Clifton Road, Building 17, Atlanta, GA 30329-4018. Offerors must be registered in the System for Award Management at the time of submission and are required to comply with all applicable FAR clauses, including 52.212-1 and 52.212-4, along with deviations such as those addressing trafficking in persons, contractor employee whistleblower rights, sustainable products and services, Buy American Act alternatives for Israeli and Korean end products, and prohibitions on unauthorized information sharing. Technical evaluation is the predominant factor in award, emphasizing experience with biomedical devices, FDA approval processes, and prior work with lateral flow technology, with price considered secondary. The contractor must deliver 200 prototype strips and 4,000 final units meeting stringent performance standards: ≤0.5% false positive rate and ≤1% false negative rate using CDC’s LAMP reaction, and must ensure full compatibility with CDC’s mass production protocols. All deliverables must conform to Section 508 accessibility requirements, including WCAG 2.0 Level AA, and vendors must provide a Voluntary Product Accessibility Template or HHS conformance checklist. The contract imposes strict security and confidentiality obligations, including mandatory non-disclosure agreements for all employees accessing sensitive information, identification protocols to distinguish contractor personnel from government staff, and prohibitions against retaining or disseminating federal records or Privacy Act data. Subcontractors must be bound by the same requirements, and all payments must be processed via the Treasury’s Invoice Processing Platform using an ACH Vendor Enrollment
CDC Office Of Acquisition Services

POSTED

4 days ago

DEADLINE

in about 24 hours
View Details
NAICS: 541714
New
DIBBS
Data Matrix & Marking ComplianceThe contract requires the application of permanent, machine-readable Data Matrix symbols to reconditioned parts in strict compliance with ISO/IEC 16022 and MIL-STD-130 standards, ensuring all markings are fully legible and durable for long-term logistics tracking. The encoded data must adhere to ANSI MH10.8.2 specifications to guarantee interoperability across military and defense supply chain systems, supporting traceability from reconditioning through final deployment. All markings must be applied using approved methods and materials to withstand environmental and operational stresses without degradation. This subcontract is issued under NAICS code 541714 by the Department of Defense through the ASC SUPPLIER OPER AE AND AF DIV, with a response deadline of July 31, 2026, and a posting date of July 23, 2026. There is no specified set-aside type or place of performance details provided, and all performance must align with the technical and regulatory requirements outlined for defense logistics compliance. The solicitation is accessible via the DIBBS portal, and proposers must ensure full understanding and capability to meet the stringent marking, encoding, and documentation standards mandated by federal defense protocols.
ASC SUPPLIER OPER AE AND AF DIV

POSTED

5 days ago

DEADLINE

in 3 days
View Details
NAICS: 541714
New
Federal
Illumina Reagent KitsThe United States Department of the Naval Medical Research Command intends to award a sole source contract to Illumina, Inc. of San Diego, California, for the purchase of Illumina Reagent Kits. This procurement is not a competitive solicitation, but responses received will be considered if submitted. The action is classified under NAICS code 541714 and will be conducted under FAR Part 12 guidelines for commercial items. All vendors must be registered in the Systems for Award Management (SAM) and possess a Unique Entity Identification Number (UEI) to be eligible for award, with SAM registration available free of charge through sam.gov or by calling (866) 606-8220. The contract is identified by solicitation number 1301397256, posted on July 23, 2026, with a response deadline of August 7, 2026. The contracting office is located in Silver Spring, Maryland, with performance expected in Frederick, Maryland. Primary point of contact is Shamai Carter, reachable at shamai.m.carter.civ@health.mil, with Nataki Johnson as the secondary contact.
Naval Medical Research Center

POSTED

5 days ago

DEADLINE

in 10 days
View Details
NAICS: 541714
New
Federal
Battlefield Pain Management – AnalgesicThis solicitation, identified as HT942726RE009 and titled Battlefield Pain Management – Analgesic, is issued under the Defense Health Agency’s prototype Other Transaction Authority (pOTA) authority pursuant to 10 U.S.C. § 4022 to acquire a single-use analgesic product for battlefield use, with the goal of achieving FDA approval for acute moderate to severe pain. The product must be administered rapidly and easily, possess a small physical profile for individual carry, and remain stable without refrigeration across extreme temperature conditions ranging from -25°C to 45°C, with a required shelf life of 2–3 years at controlled room temperature. It must comply with USP <659> packaging standards and meet stringent quality system requirements under 21 CFR Part 820, including labeling control and documentation of chemical composition. The product must be classified as DEA Schedule II or higher and may utilize a device-based delivery method such as a nasal spray or autoinjector, with physiological constraints limiting blood pressure and heart rate decreases to no more than 20% and preserving blood clotting capacity with minimal airway impact. The project spans an estimated eight years divided into three objectives—Chemistry, Manufacturing, and Controls (CMC) and stability studies over three years, non-clinical enabling studies over two years, and clinical trials and human factors testing over three years, contingent on successful completion of prior phases. Proposals must be submitted in three distinct volumes—Technical, Management, and Administrative and Cost—and adhere to strict formatting requirements including searchable PDF format, page limits for specified sections, and inclusion of a Microsoft Project file for the schedule. The submission window was extended from July 30, 2026, to August 14, 2026, with questions due by July 10, 2026, and must be sent via email to designated points of contact. Proposals must demonstrate at least one pass/fail gate condition: participation of a nontraditional defense contractor or nonprofit research institute to a significant extent; all significant participants being small businesses or nontraditional contractors; or cost-sharing from non-federal sources accounting for at least one-third of the total project cost. Evaluation focuses on technical approach, management strategy, and cost structure, with award determined by the most advantageous proposal. The agreement is not subject to the FAR or DFARS, except for referenced clauses such as DFARS 252.232-
Defense Health Agency

POSTED

5 days ago

DEADLINE

in 17 days
View Details

More opportunities from Department Of Defense → Naval Medical Research Unit South

Same awarding agency

NAICS: 334516
Federal
respiratory panels 2.1Naval Medical Research Unit South requires respiratory panels 2.1 to be delivered to its collaborator, Laboratorio de Salud Pública del Meta in Lima, Peru. While the items are available on the open market, market research has determined that only SERVICIOS DE INGENIERIA PARA LABORATORIO S A S can fully satisfy the technical and operational demands of the study, leading to a sole source intent under FAR 13.106-1(b)(i). This notice is not a solicitation for bids but an opportunity for other potential vendors to demonstrate their capability to meet the requirement. Interested parties must submit a capability statement not exceeding five pages in 10-point font or larger, including detailed management and technical information along with cost data, submitted solely via email as a Word or PDF attachment to genaro.m.vasquez.ln@health.mil with the subject line "ERP PR#1301378617". Submissions must be received by 12:00 PM local time on July 29, 2026, and must provide convincing evidence of ability to perform; inquiries or questions alone will not be accepted as responses. The government retains full discretion to determine whether to proceed with a sole source award or initiate competition based on the submissions received. The contracting office is located at 3230 Lima Pl, Washington DC, 20521, with Genaro Vasquez as the primary point of contact.
Analytical Laboratory Instrument Manufacturing

POSTED

14 days ago

DEADLINE

in about 20 hours
View Details